ziftomenib
kura oncology
['leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-dreamlike)', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders)', 'ziftomenib']
ziftomenib generates durable responses in npm1-mutant r/r aml #eha2023 #leusm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.